[go: up one dir, main page]

MX2023009660A - Compositions and methods for sublingual delivery of nicotine. - Google Patents

Compositions and methods for sublingual delivery of nicotine.

Info

Publication number
MX2023009660A
MX2023009660A MX2023009660A MX2023009660A MX2023009660A MX 2023009660 A MX2023009660 A MX 2023009660A MX 2023009660 A MX2023009660 A MX 2023009660A MX 2023009660 A MX2023009660 A MX 2023009660A MX 2023009660 A MX2023009660 A MX 2023009660A
Authority
MX
Mexico
Prior art keywords
nicotine
compositions
methods
sublingual delivery
delivery
Prior art date
Application number
MX2023009660A
Other languages
Spanish (es)
Inventor
John Docherty
Christopher Andrew Bunka
Original Assignee
Poviva Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/700,628 external-priority patent/US11700875B1/en
Priority claimed from US17/700,646 external-priority patent/US20230301341A1/en
Application filed by Poviva Corp filed Critical Poviva Corp
Priority claimed from PCT/US2023/015627 external-priority patent/WO2023183228A1/en
Publication of MX2023009660A publication Critical patent/MX2023009660A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A24B15/283—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A24B15/303—Plant extracts other than tobacco
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/42—Treatment of tobacco products or tobacco substitutes by chemical substances by organic and inorganic substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Disclosed herein are compositions and methods for oral delivery of nicotine and nicotine derivatives. In one embodiment the nicotine is delivered in an oral packets, pouches, or sachets.
MX2023009660A 2022-03-22 2023-03-20 Compositions and methods for sublingual delivery of nicotine. MX2023009660A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17/700,628 US11700875B1 (en) 2022-03-22 2022-03-22 Compositions and methods for sublingual delivery of nicotine
US17/700,646 US20230301341A1 (en) 2022-03-22 2022-03-22 Compositions and methods for sublingual delivery of nicotine
PCT/US2023/015627 WO2023183228A1 (en) 2022-03-22 2023-03-20 Compositions and methods for sublingual delivery of nicotine

Publications (1)

Publication Number Publication Date
MX2023009660A true MX2023009660A (en) 2023-10-04

Family

ID=87143072

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023009660A MX2023009660A (en) 2022-03-22 2023-03-20 Compositions and methods for sublingual delivery of nicotine.

Country Status (5)

Country Link
EP (1) EP4274437A4 (en)
JP (1) JP7675819B2 (en)
AU (1) AU2023240953B2 (en)
CA (1) CA3196911C (en)
MX (1) MX2023009660A (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US20030087937A1 (en) * 2001-10-15 2003-05-08 Nils-Olof Lindberg Nicotine and cocoa powder compositions
EP3614869B1 (en) * 2017-04-24 2024-11-06 Swedish Match North Europe AB A flavoured moist oral pouched nicotine product comprising triglyceride
EP3720498A1 (en) 2017-12-08 2020-10-14 Fertin Pharma A/S High nicotine absorption
WO2019110073A1 (en) * 2017-12-08 2019-06-13 Fertin Pharma A/S Solid oral nicotine formulation
CA3181912A1 (en) 2020-06-08 2021-12-16 Anthony Richard Gerardi Effervescent oral composition comprising an active ingredient

Also Published As

Publication number Publication date
JP2024514731A (en) 2024-04-03
CA3196911C (en) 2023-12-05
AU2023240953A1 (en) 2024-08-15
EP4274437A4 (en) 2024-11-13
CA3196911A1 (en) 2023-07-12
EP4274437A1 (en) 2023-11-15
AU2023240953B2 (en) 2025-10-02
JP7675819B2 (en) 2025-05-13

Similar Documents

Publication Publication Date Title
ZA202300151B (en) Non-tobacco oral nicotine pouch composition
WO2022047065A3 (en) Compounds and methods for treatment of viral infections
CY1120799T1 (en) AN ORAL NICOTINE PRODUCT THAT CONTAINS A POWDER CLOSED IN A WATER-SOLUBLE ENVELOPE WHERE THIS DUST CONTAINS NIKO
UA94964C2 (en) 5-substituted quinazolinone derivatives, composition containing thereof and use thereof
NZ770364A (en) Aerosol generation
MX2023000835A (en) Formulations of 19-nor c3,3- disubstituted c21-n-pyrazolyl steroid and methods of use thereof.
MX2010002319A (en) 2, 3-substituted indole derivatives for treating viral infections.
MY202614A (en) Tobacco composition
MX2024005868A (en) Oral products with nicotine-polymer complex.
ECSP11010815A (en) DRUG ADMINISTRATION SYSTEM CONTAINING PROGESTINE
MX2009010082A (en) 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same.
EP4329879A4 (en) Novel n,n-dimethyltryptamine compositions and methods
ZA202211407B (en) Compositions comprising nicotine and/or nicotine salts and ultrasonic aerosolisation of compositions comprising nicotine and/or nicotine salts
NO20051414L (en) Process for the preparation of dry powder inhalation compositions
UA101809C2 (en) Cyclopropyl amide derivatives
MEP34508A (en) Cladribine formulations for improved oral and transmucosal delivery
MX2022014007A (en) Compounds as bcl-2 inhibitors.
IL317671A (en) Anilino-pyrazole derivatives, compositions and methods thereof
EA202192669A1 (en) SOLID FORMS OF THE BETA-LACTAMASE INHIBITOR FOR ORAL DELIVERY AND THEIR USE
MX2025003937A (en) Crystal forms of an anti-sars cov-2 agent
MX2018011205A (en) Compositions useful in the prevention and/or treatment of disorders of the oral cavity, upper airways and esophagus.
CA3037257C (en) Pharmaceutical compositions comprising beclomethasone dipropionate, and formoterol fumarate dihydrate
MX365216B (en) Quick dissolving diphenhydramine oral dosage form.
MX2025012181A (en) Crystalline forms of ras inhibitors, compositions containing the same, and methods of use thereof
MX2023009660A (en) Compositions and methods for sublingual delivery of nicotine.